_her2-low-mbc-patients-report-preserved-qol-with-trastuzumab-deruxtecan.jpg "HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan from qol Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 2 min 10 sec
✓ Published: 11-Sep-2022
✓ Published: 11-Sep-2022
Description:
Prof Naoto Ueno speaks to ecancer on the patient-reported outcomes from DESTINY-Breast 04 study.nnPatients who received trastuzumab deruxtecan for human epidermal growth factor receptor 2 (HER2)-low metastatic breast cancer reported that the treatment maintained their quality of life compared to conventional chemotherapy, according to results presented today by researchers from The University of Texas MD Anderson Cancer Center at the European Society for Medical Oncology (ESMO) Congress 2022.nnB
Prof Naoto Ueno speaks to ecancer on the patient-reported outcomes from DESTINY-Breast 04 study.nnPatients who received trastuzumab deruxtecan for human epidermal growth factor receptor 2 (HER2)-low metastatic breast cancer reported that the treatment maintained their quality of life compared to conventional chemotherapy, according to results presented today by researchers from The University of Texas MD Anderson Cancer Center at the European Society for Medical Oncology (ESMO) Congress 2022.nnB
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_qed-therapeutics-qol-interview-study-for-achondroplasia.webp "As part of our commitment to best support the #achondroplasia community, QED Therapeutics recently conducted a study on the challenges and impacts of living with ACH and identified 3 relevant tools to measure Quality of Life that will be used in future clinical studies—an important milestone for research on better understanding and potentially impacting the lives of individuals with ACH! #ACHKnowledge #DwarfismAwarenessMonth")
_signaturesetupinoutlook.webp "Steps to setup your QOL Signature in MS Outlook")
_enabling-free-internet-access-in-developing-countries-using-a-participatory-design-approach.webp "In the past couple of decades we have seen a sharp rise in Internet usage, data consumption and the overall number of Internet users. With the rise of broadband connectivity, mobile Internet, mobile applications and overall web utility through localized content and services; we have been able to observe many positive effects of Internet access. Many Human Computer Interaction and Development (HCID) and Information and Communication Technology and Development (ICTD) studies in this time have demo")
⏲ 11 min 69 sec ✓ 10-Jun-2015
_qol-edp.webp "QUALITY OF LIFE- EDP")
_apollo-study-qol.webp "APOLLO study_QOL from qol")
_qol-magda-wojtkowiak.webp "QOL-Magda Wojtkowiak from qol")
_qed-therapeutics-qol-interview-study-for-achondroplasia.jpg)
_signaturesetupinoutlook.jpg)
_enabling-free-internet-access-in-developing-countries-using-a-participatory-design-approach.jpg)
_qol-edp.jpg)
_apollo-study-qol.jpg)
_qol-magda-wojtkowiak.jpg)
![[+]](/images/menu.gif){kind=small}